Frontiers in Psychological and Behavioral Science          
Frontiers in Psychological and Behavioral Science(FPBS)
ISSN:2309-012X(Print)       ISSN:2309-0138(Online)
Pathways Associating Childhood Trauma to the Neurobiology of Schizophrenia
Full Paper(PDF, 153KB)
While researchers have for decades considered the role of social factors, endocrinology, neural function, hippocampal integrity, and cognition in the development of schizophrenia, there has been a relative paucity of studies considering the participation of the stress cascade in the interplay of these elements. As described in this review, stressful exposures and stress sensitivity may plausibly be argued to play a role in the etiology, neurobiology, and course of schizophrenia and related psychotic disorders. Notably, research conducted over the last decade has made it increasingly clear that childhood traumatic experiences represent a prominent risk factor for the development of psychotic disorders, including schizophrenia. Accumulating evidence suggests that this relationship is mediated by the development of a neuropathological stress response, involving HPA axis dysregulation, aberrant functioning of different neurotransmitter systems, hippocampal damage, and memory deficits. However, it remains difficult to identify exact causal pathways linking early trauma to schizophrenia, including to the individual symptoms associated with the disorder. In addition to the strong association among early trauma, stress sensitization, and positive symptoms in schizophrenia, there is also evidence indicating that the negative and cognitive symptoms are related to these factors. However, the emergence of these symptoms may lie on a distinct and non-interacting pathway in relation to the development of the positive symptoms. The natural increases in stress sensitivity and HPA axis activity during adolescence may act on already maladaptive stress circuitry resulting from early trauma and/or a genetic predisposition to produce full blown stress sensitization and cause epigenetic effects, such as the altered methylation of different genes, that lead to schizophrenia or other psychiatric illnesses.
Keywords:Schizophrenia; Childhood Traumatic Experiences; Childhood Trauma; Early Trauma; Stress Sensitization; Stress Sensitivity; Neurobiology of Schizophrenia; Etiology of Schizophrenia; Epidemiology of Schizophrenia
Author: Eugene Ruby1, Dolores Malaspina2, Cheryl Corcoran3, Stephanie Polito1, Kevin McMahon1, Marisa Gorovitz1
1.Institute for Social and Psychiatric Initiatives – Research, Education, and Services, Department of Psychiatry, New York University School of Medicine
2.Institute for Social and Psychiatric Initiatives – Research, Education, and Services, Department of Psychiatry, New York University School of Medicine; Columbia University, Department of Psychiatry; Creedmoor Psychiatric Center, New York State Office of Mental Health
3.Columbia University, Department of Psychiatry
  1. J.D. Bremner, “Does stress damage the brain?” Biol Psychiatry, vol. 45, pp. 797-805, Apr. 1999.
  2. B. S. McEwen, “The neurobiology of stress: from serendipity to clinical relevance,” Brain Res, vol. 886, pp. 172-189, Dec. 2000.
  3. T. Frodl and V. O'Keane, “How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans,” Neurobiol Dis, vol. 52, pp. 24-37, Apr. 2013.
  4. J. Read, B. D. Perry, A. Moskowitz, and J. Connolly, “The contribution of early traumatic events to schizophrenia in some pat ients: a traumagenic neurodevelopmental model,” Psychiatry, vol. 64, pp. 319-345, Winter 2001.
  5. R. M. Sapolsky, L. C. Krey, and B. S. McEwen, “The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis,” Endocr Rev, vol. 7, pp. 284-301, Aug. 1986.
  6. M. N. Starkman, S. S. Gebarski, S. Berent, and D. E. Schteingart, “Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome,” Biol Psychiatry, vol. 32, pp. 756-765, Nov. 1992.
  7. B. Aisa, R. Tordera, B. Lasheras, J. Del Rio, and M. J. Ramirez, “Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats,” Psychoneuroendocrinology, vol. 32, pp. 256-266, Apr. 2007.
  8. N. Sousa, N. V. Lukoyanov, M. D. Madeira, O. F. Almeida, and M. M. Paula-Barbosa, “Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement,” Neuroscience, vol. 97, pp. 253-266, 2000.
  9. P. M. Plotsky and M. J. Meaney, “Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats,” Brain Res Mol Brain Res, vol. 18, pp. 195-200, May 1993.
  10. G. Rentesi, K. Antoniou, M. Marselos, A. Fotopoulos, J. Alboycharali, and M. Konstandi, “Long-term consequences of early maternal deprivation in serotonergic activity and HPA function in adult rat,” Neurosci Lett, pp. 480, 7-11, Aug. 2010.
  11. E. Martisova, M. Solas, I. Horrillo, J. E. Ortega, J. J. Meana, R.M. Tordera, and M. J. Ramírez, “Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus,” Neuropharmacology, vol. 62, pp. 1944-1953, Apr. 2012.
  12. W, Sutanto, P. Rosenfeld,, E. R. de Kloet, and S. Levine, “Long-term effects of neonatal maternal deprivation and ACTH on hippocampal mineralocorticoid and glucocorticoid receptors,” Brain Res Dev Brain Res, vol. 92, pp. 156-163, Apr. 1996.
  13. F. Benetti, P. B. Mello, J. S. Bonini, S. Monteiro, M. Cammarota, and I. Izquierdo, “Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine,” International J Dev Neurosci, vol. 27, pp. 59-64, Feb. 2009.
  14. C. Heim, D. J. Newport, S. Heit, Y. P. Graham, M. Wilcox, R. Bonsall, A. H. Miller, and C. B. Nemeroff, “Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood,” JAMA, vol. 284, pp. 592-597, Aug. 2000.
  15. P. O. McGowan, A. Sasaki, A. C. D'Alessio, S. Dymov, B. Labonté, M. Szyf, G. Turecki, and M. J. Meaney, “Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse,” Nat Neurosci, vol. 12, pp. 342-348, Mar. 2009.
  16. F. Gould, J. Clark, C. Heim, P. D. Harvey, M. Maier, C. B. Nemeroff, “The effects of child abuse and neglect on cognitive fun ctioning in adulthood,” J Psychiat Res, vol. 46, pp. 500-506, Apr. 2012.
  17. M. Majer, U. M. Nater, J. M. Lin, L. Capuron, and W. C. Reeves, “Association of childhood trauma with cognitive function in healthy adults: a pilot study,” BMC Neuro, vol. 10, p. 61, Jul. 2010.
  18. T. Brennen, M. Hazanovic, M. Zotovic, I. Blix, A. M. Skar, N. K. Prelic, I. Mehmedovici, I. Pajevic, N. Popovic, and V. GavrilovJerkovic, “Trauma exposure in childhood impairs the ability to recall specific autobiographical memories in late adolescence, ” J Trauma Stress, vol. 23, pp. 240-247, Apr. 2010.
  19. B. S. McEwen, and J. C. Wingfield, “The concept of allostasis in biology and biomedicine,” Horm Behav, vol. 43, pp. 2-15, Jan. 2003.
  20. E. Walker, V. Mittal, and K. Tessner, “Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia,” Annu Rev Clin Psychol, vol. 4, pp. 189-216, 2008.
  21. K. Yuii, M. Suzuki, and M. Kurachi, “Stress sensitization in schizophrenia,” Ann N Y Acad Sci, vol. 111, pp. 276-290, Oct. 2007.
  22. S. Bendall, H. J. Jackson, C. A. Hulbert, and P. D. McGorry, “Childhood trauma and psychotic disorders: a systematic, critical review of the evidence,” Schizophr Bull, vol. 34, pp. 568–78, May 2008.
  23. M. Heins, C. Simons, T. Lataster, S. Pfeifer, D. Versmissen, M. Lardinois M. Marcelis, P. Delespaul, L. Krabbendam, J. van Os, and I. Myin-Germeys, “Childhood trauma and psychosis: a case-control and case-sibling comparison across different levels of genetic liability, psychopathology, and type of trauma,” Am J Psychiatry, vol. 168, pp. 1286-1294, Dec. 2011.
  24. S. Larsson, O. A. Andreassen, M. Aas, J. I. Rossberg, E. Mork, N. E. Steen, E. A. Barrett, T. V. Lagerberg, D. Peleikis, I. Agartz, I. Melle, and S. Lorentzen, “High prevalence of childhood trauma in patients with schizophrenia spectrum and affective disorder,” Compr Psychiatry, vol. 54, pp. 123-7, Feb. 2013.
  25. S. L. Matheson, A. M. Sheperd, R. M. Pinchbeck, K. R. Laurens, and V. J. Carr, “Childhood adversity in schizophrenia: a syste matic meta-analysis,” Psychol Med, vol. 43, pp. 225-238, Feb. 2013.
  26. J. Read, J. van Os, A. P. Morrison, and C. A. Ross, “Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications,” Acta Psychiatrica Scandinavica, vol. 112, pp. 330-350, 2005.
  27. A. Ucok, and S. Bikmaz, “The effects of childhood trauma in patients with first-episode schizophrenia,” Acta Psychiatr Scand, vol. 116, pp. 371-377, Nov. 2007.
  28. F. Varese, F. Smeets, M. Drukker, R. Lieverse, T. Lataster, W. Viechtbauer, J. Read, J. van Os, and R. P. Bentall, “Childhood adversities increase the risk of psychosis: a meta-analysis of patient- control, prospective- and cross-sectional cohort studies,” Schizophr Bull, vol. 38, pp. 661–71, Jun. 2012.
  29. I. Myin-Germeys, J. van Os, J. E. Schwartz, A. A. Stone, and P. A. Delespaul, “Emotional reactivity to daily life stress in psychosis,” Arch Gen Psychiatry, vol. 58, pp. 1137-1144, Dec. 2001.
  30. I. Myin-Germeys, and J. van Os, “Stress-reactivity in psychosis: evidence for an affective pathway to psychosis,” Clin Psychol Rev, vol. 27, pp. 409-424, May 2007.
  31. G. W. Brown, and J. L. Birley, “Crises and life changes and the onset of schizophrenia,” J Health Soc Behav, vol. 9, pp. 203-214, Sep. 1968.
  32. R. M. Norman, and A. K. Malla, “Stressful life events and schizophrenia. I: A review of the research,” Br J Psychiatry, vol. 162, pp. 161-166, Feb. 1993.
  33. J. G. Rabkin, “Stressful life events and schizophrenia: A review of the research literature,” Psychol Bull, vol. 87, pp. 408-425, Mar. 1980.
  34. O. Agid, B. Shapira, J. Zislin, M. Ritsner, B. Hanin, H. Murad, T. Troudart, M. Bloch, U. Heresco -Levy, and B. Lerer, “Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar diso rder and schizophrenia,” Mol Psychiatry, vol. 4, pp. 163-172, Mar. 1999.
  35. S. King, D. Laplante, R. Joober, “Understanding putative risk factors for schizophrenia: retrospective and prospective studies,” J Psychiatry Neurosci, vol. 30, pp. 342-348, Sep. 2009.
  36. D. P. Laplante, R. G. Barr, A. Brunet, G. Galbaud du Fort, M. L. Meaney, J. F. Saucier, P. R. Zelazo, and S. King, “Stress during pregnancy affects general intellectual and language functioning in human toddlers,” Pediatr Res, vol. 56, pp. 400-410, Sep. 2004.
  37. K. Kleinhaus, S. Harlap, M. Perrin, O. Manor, R. Margalit-Calderon, M. Opler, Y. Friedlander, and D. Malaspina, “Prenatal stress and affective disorders in a population birth cohort,” Bipolar Disord, vol. 15, pp. 92-99, Feb. 2013.
  38. S. N. Brixey, B. J. Gallagher, J. A. McFalls 3rd Jr., and L. F. Parmelee, “Gestational and neonatal factors in the etiology of schizophrenia,” J Clin Psychol, vol. 49, pp. 447-456, May 1993.
  39. G. Boog, “Obstetrical complications and subsequent schizophrenia in adolescent and young adult offsprings: is there a relationship?” Eur J Obstet Gynecol Reprod Biol, vol. 114, pp. 130-136, Jun. 2004.
  40. J. M. Hollister, P. Laing, and S.A. Mednick, “Rhesus incompatibility as a risk factor for schizophrenia in male adults,” Arch Gen Psychiatry, vol. 53, pp. 19-24, Jan. 1996.
  41. E. Susser, R. Neugebauer, H. W. Hoek, A. S. Brown, S. Lin, D. Labovitz, and J. M. Gorman. “Schizophrenia after prenatal famine. further evidence,” Arch Gen Psychiatry, vol. 53, pp. 25-31, Jan. 1996.
  42. T. C. Jordan, K. F. Howells, N. McNaughton, and P. L. Heatlie, “Effects of early undernutrition on hippocampal development and function,” Res Exp Med (Berl), vol. 180, pp. 201-207, 1982.
  43. M. M. Paula-Barbosa, J. P. Andrade, J. L. Castedo, F. P. Azevedo, I. Camões, B. Volk, and M. A. Tavares, “Cell loss in the cerebellum and hippocampal formation of adult rats after long-term low-protein diet,” Exp Neurol, vol. 103, pp. 186-193, Feb. 1989.
  44. A. N. Brooks, and J. R. Challis, “Adrenocorticotrophin responses to hypoxaemia in fetal sheep are sustained in the presence of naloxone,” J Dev Physiol, vol. 17, pp. 221-225, May 1992.
  45. C. Nyakas, B. Buwalda, R. J. Kramers, J. Traber, and P. G. Luiten, “Postnatal development of hippocampal and neocortical cholinergic and serotonergic innervation in rat: effects of nitrite-induced prenatal hypoxia and nimodipine treatment,” Neuroscience, vol. 59, pp. 541-559, Apr. 1994.
  46. A. Sharma, N. Valadi, A. H. Miller, and B. D. Pearce, “Neonatal viral infection decreases neuronal progenitors and impairs adult neurogenesis in the hippocampus,” Neurobiol Dis, vol. 11, pp. 246-256, Nov. 2002.
  47. M. Issa, W. Rowe, S. Gauthier, and M. J. Meaney, “Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats,” J Neurosci, vol. 10, pp. 3247-3254, Oct. 1990.
  48. P. W. Landfield, R. K. Baskin, and T. A. Pitler, “Brain aging correlates: retardation by hormonal-pharmacological treatments,” Science, vol. 214, pp. 581-584, Oct. 1981.
  49. E. F. Walker, P. A. Brennan, M. Esterberg, J. Brasfield, B. Pearce, M. T. Compton, “Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth,” J Abnorm Psychol, vol. 119, pp. 401-408, May 2010.
  50. D. J. Walder, E. F. Walker, and R. J. Lewine, “Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia,” Biol Psychiatry, vol. 48, pp. 1121-1132, Dec. 2000.
  51. A. J. Bradley and T. G. Dinan, “A systematic review of hypothalamic-pituitary-adrenal axis function in Schizophrenia: implications for mortality,” J Psychopharmacol, vol. 24, pp. 91-118, Nov. 2010.
  52. C. Braehler, D. Holowka, A. Brunet, S. Beaulieu, T. Baptista, J. B. Debruille, C. D. Walker, and S. King, “Diurnal cortisol in schizophrenia patients with childhood trauma,” Schizophr Res, vol. 79, pp. 353-354, Nov. 2005.
  53. L. F. Valiquette, “Association between self-reported childhood maltreatment and cortisol profiles in psychotic patients,” Ann Arbor, MI: Proquest, UMI Dissertations Publishing, 2008.
  54. R. Tandon, C. Mazzara, J. DeQuardo, K. A. Craig, J. H. Meador-Woodruff, R. Goldman, and J. F. Greden, “Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome,” Biol Psychiatry, vol. 29, pp. 953-964, May 1991.
  55. V. K. Yeragani, “The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls,” Can J Psychiatry, vol. 35, pp. 128-132, Mar. 1990.
  56. V. Mondelli, P. Dazzan, N. Hepgul, M, Di Forti, M. Aas, A. D’Albenzio, M. Di Nicola, H. Fisher, R. Handley, T. R. Marques, C. Morgan, S. Navari, H. taylor, A. Papadopoulos, K. J. Aitchison, R. M. Murray, and C. M. Pariante, “Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment,” Schizophr Res, vol. 116, pp. 234-242, Feb. 2010.
  57. E. Fries, J. Hesse, J Hellhammer, and D. H. Hellhammer, “A new view on hypocortisolism,” Psychoneuroendocrinology, vol. 30, pp. 1010-1016, Nov. 2005.
  58. E. J. Sachar, “Evidence for neuroendocrine abnormalities in the major mental illnesses,” Res Publ Assoc Res Nerv Ment Dis, vol. 54, pp. 347-358, 1975.
  59. S. Cohrs, C. Röher, W. Jordan, A. Meier, G. Huether, W, Wuttke, E. Rüther, and A. Rodenbeck, “The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects,” Psychopharmacology (Berl), vol. 185, pp. 11-18, Mar. 2006.
  60. K. Mann, W. Rossbach, M. J. Müller, F. Müller-Siecheneder, T. Pott, I. Linde, R. W. Dittmann, and Hiemke, “Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine,” Psychoneuroendocrinology, vol. 31, pp. 256-264, Feb. 2006.
  61. X. Y. Zhang, D. F. Zhou, L. Y. Cao, G. Y. Wu, and Y. C. Shen, “Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics,” Neuropsychopharmacology, vol. 30, pp. 1532-1538, Aug. 2005.
  62. T. Paus, M. Keshavan, and J. N. Giedd, “Why do many psychiatric disorders emerge during adolescence?” Nat Rev Neurosci, vol. 9, pp. 947-57, Dec. 2008.
  63. C. Corcoran, E. Walker, R. Huot, V. Mittal, K. Tessner, L. Kestler, and D. Malaspina, “The stress cascade and schizophrenia: etiology and onset,” Schizophr Bull, vol. 29, pp. 671-692, 2003.
  64. C. W. Holtzman, D. I. Shapiro, H. D. Trotman, and E. F. Walker, “Stress and the prodromal phase of psychosis,” Curr Pharm Des, vol. 18, pp. 527-533, 2012.
  65. E. F. Walker, Z. Sabuwalla, and R. Huot, “Pubertal neuromaturation, stress sensitivity, and psychopathology,” Dev Psychopathol, vol. 16, pp. 807-824, Fall 2004.
  66. E. K. Adam, “Transactions among adolescent trait and state emotion and diurnal and momentary cortisol activity in naturalistic settings,” Psychoneuroendocrinology, vol. 31, pp. 664-679, Jun. 2006.
  67. E. F. Walker, D. J. Walder, and F. Reynolds, “Developmental changes in cortisol secretion in normal and at-risk youth,” Dev Psychopathol, vol. 13, pp. 721-732, Summer 2001.
  68. C. M. Buchanan, J. S. Eccles, and J. B. Becker, “Are adolescents the victims of raging hormones: evidence for activational effects of hormones on moods and behavior at adolescence,” Psychol Bull, vol. 111, pp. 62-107, Jan. 1992.
  69. E. F. Walker, H. D. Troutman, H.D., B. D. Pearce, G. Addington, K. S. Cadenhead, B. A. Cornblatt, R. Heinssen, D. H. Mathalon , D. O. Perkins, I. J. Seidman, M. T. Tsuang, T. D. Cannon, T. H. McGlashan, and S. W. Woods, “Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study,” Biol Psychiatry, vol. 74, pp. 410-417, Sep. 2013.
  70. M. D. Nelson, A. J. Saykin, L. A. Flashman, H. J. Riordan, “Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study,” Arch Gen Psychiatry, vol. 55, pp. 433-440, May 1998.
  71. F. Adriano, C. Caltagirone, and G. Spalletta, “Hippocampal volume reduction in first -episode and chronic schizophrenia: a review and meta-analysis,” Neuroscientist, vol. 18, pp. 180-200, Apr. 2012.
  72. J. N. Giedd, N. O. Jeffries, J. Blumenthal, F. X. Castellanos, A. C. Vaituzis, T. Fernandez, S. D. Hamburger, H. Liu, J. Nelson, J. Bedwell, L. Tran, M. Lenane, R. Nicolson, and J. L. Rapoport, “Childhood-onset schizophrenia: progressive brain changes during adolescence,” Biol Psychiatry, vol. 46, pp. 892-898, Oct. 1999.
  73. L. K. Jacobsen, J. N. Giedd, F. X. Castellanos, A. C. Vaituzis, S. D. Hamburger, S. Kumra, M. C. Lenane, and J. L. Rapoport, “Progressive reduction of temporal lobe structures in childhood-onset schizophrenia,” Am J Psychiatry, vol. 155, pp. 678-685, May 1998.
  74. R. E. Gur, P. Cowell, B. I. Turetsky, F. Gallacher, T. Cannon, W. Bilker, and R. C. Gur, “A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures,” Arch Gen Psychiatry, vol. 55, pp. 145-152, Feb. 1998.
  75. D. V. Jeste and Lohr, “Hippocampal pathologic findings in schizophrenia. A morphometric study,” Arch Gen Psychiatry, vol. 46, pp. 1019-1024, Nov. 1989.
  76. G. Rosoklija, G. Toomayan, S. P. Ellis, J. Keilp, J. J. Mann, N. Latov, A. P. Hays, and A. J. Dwork, “Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings,” Arch Gen Psychiatry, vol. 57, pp. 349-356, Apr. 2000.
  77. W. F. Baare, C. J. van Oel, H. E. Hulshoff Pol, H. G. Schnack, S. Durston, M. M. Sitskoorn, and R. S. Kahn. “Volumes of brain structures in twins discordant for schizophrenia,” Arch Gen Psychiatry, vol. 58, pp. 33-40, Jan. 2001.
  78. R. L. Suddath, G. W. Christison, E. F. Torrey, M. F. Casanova, D. R. Weinberger, “Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia,” N Engl J Med, vol. 322, pp. 789-794, Mar. 1990.
  79. M. J. Webster, C. S. Weickert, M. M. Herman, J. E. Kleinman, “BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex,” Brain Res Dev Brain Res, vol. 139, pp. 139-150, Dec. 2002.
  80. C. Curran, N. Byrappa, and A. McBride, “Stimulant psychosis: systematic review,” Br J Psychiatry, vol. 185, pp. 196-204, Sep. 2004.
  81. J. M. De Lecuona, J. K. Sunny, N. Iqbal, and G. M. Asnis, “Dopamine hypothesis of schizophrenia revisited,” Psychiatr Ann, vol. 23, pp. 179-185, Apr. 1993.
  82. R. H. Bouchard, C. Mérette, E. Pourcher, M. F. Demers, J. Villeneuve, M. H. Roy-Gagnon, Y. Gauthier, D. cliché, A. Labelle, M. J. Filteau, M. A. Roy, M. Maziade, “Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia,” J Clin Psychopharmacol, vol. 20, pp. 295-304, Jun. 2000.
  83. S. Burton, “Symptom domains of schizophrenia: the role of atypical antipsychotic agents,” JPsychopharmacol, vol. 20, pp. 6-19, Nov. 2006.
  84. O. Virit, A. Altindag, F. Balbul, H. A. Savas, A. Dalkilic, “Long-acting typical and atypical antipsychotics in treatment of schizophrenia: a retrospective comparison,” Bulletin of Clinical Psychopharmacology (Klinik Psikofarmakoloji Bulteni), vol. 19, pp. 119-127, Feb. 2009.
  85. C. de Weerth, R. H. Zijl, and J. K. Buitelaar, “Development of cortisol circadian rhythm in infancy,” Early Hum Dev, vol. 73, pp. 39-52, Aug. 2003.
  86. D. Biron, C. Dauphin, and T. Di Paolo, “Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors,” Neuroendocrinology, vol. 55, pp. 468-476, Apr. 1992.
  87. L. J. Madden, C. T. Flynn, M. A. Zandonatti, M. May, L. H. Parsons, S. N. Katner, S. J. Henriksen, H. S. Fox, “Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities,” Neuropsychopharmacology, vol. 30, pp. 350-359, Feb. 2005.
  88. C. A. Munro, M. E. McCaul, L. M. Oswald, D. F. Wong, Y. Zhoum J. Brasic, H. Kuwabara, A. Kumar, M. Alexander, W. Ye, and G. S. Wand, “Striatal dopamine release and family history of alcoholism,” Alcohol Clin Exp Res, vol. 30, pp. 1143-1151, Jul. 2006.
  89. L. M. Oswald, D. F. Wong, M. McCaul, Y. Zhou, H. Kuwabara, L. Choi, J. Brasic, J., and G. S. Wand, “Relationships among ventr al striatal dopamine release, cortisol secretion, and subjective responses to amphetamine,” Neuropsychopharmacology, vol. 30, pp. 821-832, Apr. 2005.
  90. M. F. Piacentini, R. Meeusen, L. Buyse, G. De Schutter, and K. De Meirleir, “Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor,” Br J Sports Med, vol. 38, pp. 129-133, Apr. 2004.
  91. G. Rentesi, K. Antoniou, M. Marselos, M. Syrrou, Z. Papadopoulou-Daifoti, and M. Konstandi, “Early maternal deprivation-induced modifications in the neurobiological, neurochemical and behavioral profile of adult rats,” Behav Brain Res, vol. 244, pp. 29-37, May 2013.
  92. J. C. Pruessner, F. Champagne, M. J. Meaney, and A. Dagher, “Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride,” J Neurosci, vol. 24, pp. 2825-2831, Mar. 2004.
  93. A. F. Schatzberg, A. J. Rothschild, P. J. Langlais, E. D. Bird, and J. O. Cole, “A corticosteroid/dopamine hypothesis for psychotic depression and related states,” J Psychiatr Res, vol. 19, pp. 57-64, 1985.
  94. A. F. Schatzberg, and A. J. Rothschild, “The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression,” Ann N Y Acad Sci, vol. 537, pp. 462-471, 1988.
  95. C. M. Adler, A. K. Malhotra, I. Elman, T. Goldberg, M. Egan, D. Pickar, and A. Breier, “Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia,” Am J Psychiatry, vol. 156, pp. 1646-1649, Oct. 1999.
  96. J. H. Krystal, L. P. Karper, J. P. Seibyl, G. K. Freeman, R. Delaney, J. D. Bremner, G. R. Heninger, M. B. Bowers Jr, and D. S. Charney, “Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans,” Psychotomimetic, perceptual, cognitive, and neuroendocrine responses,” Arch Gen Psychiatry, vol. 51, pp. 199-214, Mar. 1994.
  97. J. W. Newcomer, N. B. Farber, V. Jevtovic-Todorovic, G. Selke, A. K. Melson, T. Hershey, S. Craft, and J. W. Olney, “Ketamineinduced NMDA receptor hypofunction as a model of memory impairment and psychosis,” Neuropsychopharmacology, vol. 20, pp. 106-118, Feb. 1999.
  98. K. Mirnics, F. A. Middleton, A. Marquez, D. A. Lewis, and P. Levitt, “Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex,” Neuron, vol. 28, pp. 53-67, Oct. 2000.
  99. D. A. Lewis, D. W. Volk, and T. Hashimoto, “Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction,” Psychopharmacology (Berl), vol. 174, pp. 143-150, Jun. 2004.
  100. T. U. Woo, R. E. Whitehead, D. S. Melchitzky, D. A. Lewis, “A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia,” Proc Natl Acad Sci U S A, vol. 95, pp. 5341-5346, Apr. 1998.
  101. F. M. Benes, “Evidence for altered trisynaptic circuitry in schizophrenic hippocampus,” Biol Psychiatry, vol. 46, pp. 589-599, Sep. 1999.
  102. D. C. D'Souza, “gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation,” Biol Psychiatry, vol. 59, pp. 128-137, Jan. 2006.
  103. J. P. Lindenmayer, M. Adityanjee, Vital-Herne, N. Bark, S. Grochowski, and N. Moynihan, “Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients,” Biol Psychiatry, vol. 42, pp. 6-12, Jul. 1997.
  104. F. E. Scheepers, C. C. Gespen de Wied, and R. S. Kahn, “The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia,” J Clin Psychopharmacol, vol. 21, pp. 575-582, Dec. 2001.
  105. S. Kapur, G. Remington, C. Jones, S. Houle, and R. Zipursky, “Typical vs. atypical: lessons from pet studies of 5 -HT2A and D2 occupancy of antipsychotics,” Schizophr Res, vol. 24, p. 167, Mar. 1997.
  106. F. X. Vollenweider, M. F. Vollenweider-Scherpenhuyzen, A. Bä bler, H. Vogel, and D. Hell, “Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action,” Neuroreport, vol. 9, pp. 3897-3902, Dec. 1998.
  107. R. M. Bilder R. S. Goldman, J. Volavka, P. Czobor, M. Hoptman, B. Sheitman, J. P. Lindenmayer, L. Citrome, J. McEvoy, M. Kunz, M., Chakos, T. B. Cooper, T.L. Horowitz, and J. A. Lieberman, “Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder,” Am J Psychiatry, vol. 159, pp. 1018-1028, Jun. 2002.
  108. R. S. Keefe, S. G. Silva, D. O. Perkins, and J. A. Liebman, “The effects of atypical antipsychotic drugs on nerocognitive impairment in schizophrenia: a review and meta-analysis,” Schizophr Bull, vol. 25, pp. 201-222, 1999.
  109. H. Y. Meltzer, “The role of serotonin in antipsychotic drug action,” Neuropsychopharmacology, vol. 21, pp. 106S-115S, Oct. 1999.
  110. M. T. Lowy, L. Gault, and B. K. Yamamoto, “Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus,” J Neurochem, vol. 61, pp. 1957-1960, Nov. 1993.
  111. B. Moghaddam, “Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia,” J Neurochem, vol. 60, pp. 1650-1657, May 1993.
  112. M. Orchinik, N. G. Weiland, and B. S. McEwen, “Adrenalectomy selectively regulates GABAA receptor subunit expression in the hippocampus,” Mol Cell Neurosci, vol. 5, pp. 451-458, Oct. 1994.
  113. Y. Watanabe, E. Gould, H. A. Cameron, D. C. Daniels, and B. S. McEwen, “Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons,” Hippocampus, vol. 2, pp. 431-435, Oct. 1992.
  114. A. M. Magariños, A. Deslandes, B. S. McEwen, “Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress,” Eur J Pharmacol, vol. 371, pp. 113-22, Apr. 1999.
  115. C. S. Weickert, T. M. Hyde, B. K. Lipska, M. M. Herman, D. R. Weinberger, and J. E. Kleinman, “Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia,” Mol Psychiatry, vol. 8, pp. 592-610, Jun. 2003.
  116. M. Thompson Ray, C. S. Wieckert, E. Wyatt, and M. J. Webster, “Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders,” J Psychiatry Neurosci, vol. 36, pp. 195-203, May 2011.
  117. B. Cheng, and M. P. Mattson, “NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults,” Brain Res, vol. 640, pp. 56-67, Mar. 1994.
  118. C. Hyman, M. Hofer, Y. A. Barde, M. Juhasz, G. D. Yancopoulos, S. P. Squinto, R. M. Lindsay, “BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra,” Nature, vol. 350, pp. 230-232, Mar. 1991.
  119. O. D. Guillin, J. Diaz, P. Carroll, J. C. Schwartz, P. Sokoloff, “BDNF controls dopamine D3 receptor expression and triggers behavioral sensitization,” Nature, vol. 411, pp. 86-89, May 2001.
  120. M. A. Smith, S. Makino, R. Kvetnansky, R. M. Post, “Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus,” Journal Neurosci, vol. 15, pp. 1768-1777, Mar. 1995.
  121. M. Bai, X. Zhu, Y. Zhang, S. Zhang, L. Zhang, S. Yao, and X. Zhang, “Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life,” PLoS One, vol. 7, p. e46921, 2012.
  122. M. Roceri, W. Hendriks, G. Racaqni, B. A. Ellenbroek, and M. A. Riva, “Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus,” Mol Psychiatry, vol. 7, pp. 609-616, 2002.
  123. T. L. Roth, F. D. Lubin, A. J. Funk, J. D. Sweatt, “Lasting epigenetic influence of early-life adversity on the BDNF gene,” Biol Psychiatry, vol. 65, pp. 760-769, May 2009.
  124. C. Corcoran, L. Mujica-Parodi, S. Yale, D. Leitman, D., Malaspina, “Could stress cause psychosis in individuals vulnerable to schizophrenia?” CNS Spectr, vol. 7, pp. 41-32, Jan. 2002.
  125. I. I. Gottesman, “Origins of Schizophrenia: Past as Prologue." In R. Plomin and G.E. McLearn (Eds.), Nature, Nurture, and Psychology, Washington, DC, US: American Psychological Association, pp. 231-244, 1993.
  126. D. Bonsch, M. Wunschel, B. Lenz, G. Janssen, M. Weisbrod, and H. Sauer, “Methylation matters? Decreased methylation status of genomic DNA in the blood of schizophrenic twins,” Psychiatry Res, vol. 198, pp. 533-537, Aug. 2012.
  127. I. C. Weaver, N. Cervoni, F. A. Champagne, A. C. D'Alessio, S. Sharma, J. R. Seckl, S. Dymov, M. Szyf, and M. J. Meaney, “Epigenetic programming by maternal behavior,” Nat Neurosci, vol. 7, pp. 847-854, Aug. 2004.
  128. C. Caldji, B. Tannenbaum, S. Sharma, D. Francis, P. M. Plotsky, M. J. Meaney, “Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat,” Proc Natl Acad Sci U S A, vol. 95, pp. 5335-5340, Apr. 1998.
  129. D. Liu, J. Diorio, B. Tannenbaum, C. Caldji, D. Francis, A. Freedman, S. Sharma, D. Pearson, P. M. Plotsky, and M. J. Meaney, “Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress,” Science, vol. 277, pp. 1659-1662, Sep. 1997.
  130. B. Labonte, M. Suderman, G. Maussion, L. Navaro, V. Yerko, I. Mahar, A. Bureau, N. Mehawar, M. Zhyf, M. J. Meaney, and G. Turecki, “Genome-wide epigenetic regulation by early-life trauma,” Arch Gen Psychiatry, vol. 69, pp. 722-731, Jul. 2012.
  131. C. Shannon, K. Douse, C. McCusker, L. Feeney, S. Barrett, and C. Mulholland “The association between childhood trauma and memory functioning in schizophrenia,” Schizophr Bull, vol. 37, pp. 531-537, May 2011.
  132. P. H. Lysaker, P. Meyer, J. D. Evans, K. A. Marks, “Neurocognitive and symptom correlates of self-reported childhood sexual abuse in schizophrenia spectrum disorders,” Ann Clin Psychiatry, vol. 13, pp. 89-92, Jun. 2001.
  133. A. Aleman, R. Hijman, E. H. de Haan, and R. S. Kahn, “Memory impairment in schizophrenia: a meta-analysis,” Am J Psychiatry, vol. 156, pp. 1358-1366, Sep. 1999.
  134. R. Heaton, J. S. Paulsen, L. A. McAdams, J. Kuck, S. Zisook, D. Braff, J. Harris, and D. V. Jeste, “Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia,” Arch Gen Psychiatry, vol. 51, pp. 469-476, Jun. 1994.
  135. L. McClain, “Encoding and retrieval in schizophrenics' free recall,” J Nerv Ment Dis, vol. 171, pp. 471-479, Aug. 1983.
  136. J. M. Gold, C. Randolph, C. J. Carpenter, T. E. Goldberg, and D. M. Weinberger, “Forms of memory failure in schizophrenia,” J Abnorm Psychol, vol. 101, pp. 487-494, Aug. 1992.
  137. R. W. Heinrichs, and A. G. Awad, “Neurocognitive subtypes of chronic schizophrenia,” Schizophr Res, vol. 9, pp. 49-58, Mar. 1993.
  138. J. S. Paulsen, R. K. Heaton, J. R. Sadek, W. Perry, D. C. Delis, D. Braff, J. Kuck, S. Zusook, and D. V. Jeste, “The nature o f learning and memory impairments in schizophrenia,” J Int Neuropsychol Soc, vol. 1, pp. 88-99, Jan. 1995.
  139. J. L. Iddon, P. J. McKenna, B. J. Sahakian, T. W. Robbins, “Impaired generation and use of strategy in schizophrenia: evidenc e from visuospatial and verbal task,” Psychol Med, vol. 28, pp. 1049-1062, Aug. 1998.
  140. S. D. Koh, L. Kayton, and R. Berry, “Mnemonic organization in young nonpsychotic schizophrenics,” J Abnorm Psychol, vol. 81, pp. 299-310, Jun. 1973.
  141. S. D. Koh and R. A. Peterson, “Encoding orientation and the remembering of schizophrenic young adults,” J Abnorm Psychol, vol. 87, pp. 303-313, Jun. 1978.
  142. C. Ranganath, M. J. Minzenberg, and J. D. Ragland, “The cognitive neuroscience of memory function and dysfunction in schizophrenia,” Biol Psychiatry, vol. 64, pp. 18-25, Jul. 2008.
  143. G. Brebion, X. Amador, M. J. Smith, and J. M. Gorman, “Mechanisms underlying memory impairment in schizophrenia,” Psychol Med, vol. 27, pp. 383-393, Mar. 1997.
  144. M. Stone, J. D. Gabrieli, G. T. Stebbins, and E. V. Sullivan, “Working and strategic memory deficits in schizophrenia,” Neuropsychology, vol. 12, pp. 278-288, Apr. 1998.
  145. E. Duzel, F. Vargha-Khadem, H. J. Heinze, and M. Mishkin, “Brain activity evidence for recognition without recollection after early hippocampal damage,” Proc Natl Acad Sci U S A, vol. 98, pp. 8101-8106, Jul. 2001.
  146. A. P. Yonelinas, “The contribution of recollection and familiarity to recognition and source-memory judgments: a formal dual-process model and an analysis of receiver operating characteristics,” J Exp Psychol Learn Mem Cogn, vol. 25, pp. 1415-1434, Nov. 1999.
  147. A. P. Yonelinas, “Recognition memory ROCs and the dual-process signal-detection model: comment on Glanzer, Kim, Hilford and Adams,” J Exp Psychol Learn Mem Cogn, vol. 25, pp. 514–521, Mar. 1999.
  148. A. Gras-Vincendon, J. M. Danion, D. Grangé, M. Bilik, D. Willard-Schroeder, J. P. Sichel, and L. Singer, “Explicit memory, repetition priming and cognitive skill learning in schizophrenia,” Schizophr Res, vol. 13, pp. 117-126, Sep. 1994.
  149. M. Myles-Worsley, “Implicit versus explicit memory in schizophrenia,” Schizophr Res, vol. 4, pp. 389, 1991.
  150. K. Zierhut, B. Bogerts, B., Schott, D. Fenker, M. Walter, D. Albrecht, J. Steiner, H. Schütze, G. Northoff, E. Düzel, and K Schiltz, "The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia,” Psychiatry Res, vol. 183, pp. 187-194, Sep. 2010.
  151. A. J. Russell, J. C. Munro, P. B. Jones, D. R. Hemsley, and R. M. Murray, “Schizophrenia and the myth of intellectual decline,” Am J Psychiatry, vol. 154, pp. 635-639, May 1997.
  152. W. S. Kremen, S. L. Buka, L. J. Seidman, J. M. Goldstein, D. Koren, and M. T. Tsuang, “IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study,” Am J Psychiatry, vol. 155, pp. 672-677, May 1998.
  153. I. Myin-Germeys, L. Krabbendam, J. Jolles, P. A. Delespaul, and J. van Os, “Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study,” Am J Psychiatry, vol. 159, pp. 443-449, Mar. 2002.
  154. K. Daalman, K. M. Diederen, E. M. Derks, R. van Lutterveld, R. S. Kahn, and I. E. Sommer, “Childhood trauma and auditory verbal hallucinations,” Psychol Med, vol. 42, pp. 2475-2484, Dec. 2012.
  155. J. L. Thompson, M. Kelly, D. Kimhy, J. M. Harkavy-Friedman, S. Kahn, J. W. Messinger, S. Schobel, R. Goetz, D. Malaspina, D., and C. Corcoran, “Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis,” Schizophr Res, vol. 108, pp. 176-181, Mar. 2009.
  156. C. L. Whitfield, S. R. Dube, V. J. Felitti, and R. F. Anda, “Adverse childhood experiences and hallucinations,” Child Abuse Negl, vol. 29, pp. 797-810, Jul. 2005.
  157. P. H. Lysaker, R. S. Lancaster, M. A. Nees, and L. W. Davis, “Neuroticism and visual memory impairments as predictors of the severity of delusions in schizophrenia,” Psychiatry Res, vol. 119, pp. 287-292, Aug. 2003.
  158. P. H. Lysaker, “Childhood sexual trauma and psychosocial functioning in adults with schizophrenia,” Psychiatr Serv, vol. 52, pp.1485-1488, Nov. 2001.
  159. C. M. Corcoran, C. Smith, D. McLaughlin, A. Auther, D. Malaspina, and B. Cornblatt, “HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia,” Schizophr Res, vol. 135, pp. 170-174, Mar. 2012.
  160. J. E. Devylder, S. Ben-David, S. A. Schobel D. Kimhy, D. Malaspina, C. M. Corcoran, “Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis,” Psychol Med, vol. 43, pp. 259-268, Feb. 2013.
  161. A. P. Morrison, L. Frame, W. Larkin, “Relationships between trauma and psychosis: a review and integration,” Br J Clin Psychol, vol. 42, pp. 331-353, Nov. 2003.
  162. C. L. Harrison, and D. Fowler, “Negative symptoms, trauma, and autobiographical memory: an investigation of individuals recovering from psychosis,” J Nerv Ment Dis, vol. 192, pp. 745-753, Nov. 2004.
  163. H. G. Stampfer, “’Negative symptoms’: a cumulative trauma stress disorder?” Aust N Z J Psychiatry, vol. 24, pp. 516-528, Dec. 1990.
  164. R. W. Butler, K. T. Mueser, J. Sprock, and D. L. Braff, “Positive symptoms of psychosis in posttraumatic stress disorder,” Biol Psychiatry, vol. 39, pp. 839-844, May 1996.
  165. D. David, G. S. Kutcher, E. I. Jackson, T. A. Mellman, “Psychotic symptoms in combat-related posttraumatic stress disorder,” J Clin Psychiatry, vol. 60, pp. 29-32, Jan. 1999.
  166. R. Yehuda, S. L. Halligan, and R. Grossman, “Childhood trauma and risk for PTSD: relationship to intergenerational effects of trauma, parental PTSD, and cortisol excretion,” Dev Psychopathol, vol. 13, pp. 733-753, Summer 2001.
  167. M. D. De Bellis, A. S. Baum, B. Birmaher, M. S. Keshavan, C. H. Eccard, A. M. Boring, F. J. Jenkins, and N. D. Ryan, “A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems”, Biol Psychiatry, vol. 45, pp. 1259-1270, May 1999.
  168. V. G. Carrion, C. F. Weems, and A. L. Reiss, “Stress predicts brain changes in children: a pilot longitudinal study on youth stress, postraumatic stress disorder, and the hippocampus,” Pediatrics, vol. 119, pp. 509-516, Mar. 2007.
  169. R. Yehuda, J. A. Golier, P. D. Harvey, K. Stavitsky, S. Kaufman, R. A. Grossman, and L Tischler, “Relationship between cortisol and age-related memory impairments in Holocaust survivors with PTSD,” Psychoneuroendocrinology, vol. 30, pp. 678-687, Aug. 2005.
  170. J. D. Bremner, P. Randall, T. M. Scott, R. A. Bronen, J. P. Seibyl, S. M. Southwick, R. C. Delaney, G. McCarthy, D. S. Charne y, and R. B. Innis, “MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder,” Am J Psychiatry, vol. 152, pp. 973-981, Jul. 1995.
  171. R. Yehuda, “Status of glucocorticoid alterations in post-traumatic stress disorder,” Ann N Y Acad Sci, vol. 1179, pp. 56-69, Oct. 2009.
  172. B. M. Elzinga, C. G. Schmahl, E. Vermetten, R. van Dyck, and J. D. Bremner, “Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD,” Neuropsychopharmacology, vol. 28, pp. 1656-1665, Sep. 2003.
  173. I. Liberzon, J. L. Abelson, S. B. Flagel, J. Raz, J., and E. A. Young, “Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study,” Neuropsychopharmacology, vol. 21, pp. 40-50, Jul. 1999.
  174. M. Vogel, J. Meier, S. Grönke, M. Waage, W. Schneider, H. J. Freyberger, T. Klauer, “Differential effects of childhood abuse and neglect: mediation by posttraumatic distress in neurotic disorder and negative symptoms in schizophrenia?” Psychiatry Res, vol. 189, pp. 121-127, Aug. 2011.
  175. A. Soliman, G. A. O’Driscoll, J. Pruessner, A. L. Holahan, I. Boileau, D. Gagnon, A. Dagher, “Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study,” Neuropsychopharmacology, vol. 33, pp. 2033-2041, Jul. 2008.
  176. J. Katsanis, W. G. Iacono, and M. Beiser, “Anhedonia and perceptual aberration in first-episode psychotic patients and their relatives,” J Abnorm Psychol, vol. 99, pp. 202-206, May 1990.
  177. B. A. Clementz, W. M. Grove, J. Katsanis, and W. G. Iacono, “Psychometric detection of schizotypy: perceptual aberration and physical anhedonia in relatives of schizophrenics,” J Abnorm Psychol, vol. 100, pp. 607-612, Nov. 1991.
  178. T. R. Barnes, D. A. Curson, P. F. Liddle, and M. Patel, “The nature and prevalence of depression in chronic schizophrenic in-patients,” Br J Psychiatry, vol. 154, pp. 486-491, Apr. 1989.
  179. S. J. Bartels, and R. E. Drake, “Depressive symptoms in schizophrenia: comprehensive differential diagnosis,” Compr Psychiatry, vol. 29, pp. 467-483, Sep.-Oct. 1988.
  180. S. K. Chaturvedi, G. P. Rao, P. J. Mathai, S. Sarmukaddam, and P. S. Gopinath, “Negative symptoms in schizophrenia and depression,” Indian J Psychiatry, vol. 27, pp. 237-241, Jul.-Sep. 1985.
  181. V. J. Felitti, R. F. Anda, D. Nordenberg, D. F. Williamson, A. M. Spitz, V. Edwards, M. P. Koss, and J. S. Marks, “Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences(ACE) Study,” Am J Prev Med, vol. 14, pp. 245-258, May 1998.
  182. C. Heim, D. J. Newport, T. Mletzko, A. H. Miller, and C. B. Nemeroff, “The link between childhood trauma and depression: insights from HPA axis studies in humans,” Psychoneuroendocrinology, vol. 33, pp. 693-710, Jul. 2008.
  183. J. Hill, “Childhood trauma and depression,” Curr Opin Psychiatry, vol.16, pp. 3-6, Jan. 2003.
  184. P. Linkowski, J. Mendlewicz, M. Kerkhofs, R. Leclercq, J. Golstein, M. Brasseur, G. Copinschi, and E. Van Cauter, “24 -hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment,” J Clin Endocrinol Metab, vol. 65, pp. 141-152, Jul. 1987.
  185. C. M. Pariante, “The glucocorticoid receptor: part of the solution or part of the problem?” J Psychopharmacol, vol. 20, pp. 79-84, Jul. 2006.
  186. J. C. Nelson, J. M. Davis, “DST studies in psychotic depression: a meta-analysis,” Am J Psychiatry, vol. 154, pp. 1497-1503, Nov. 1997.
  187. R. F. Anton, “Urinary free cortisol in psychotic depression,” Biol Psychiatry, vol. 22, pp. 24-34, Jan. 1987.